Wolverine Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-500
Closed -$97K 2369
2021
Q1
$97K Buy
+500
New +$100K ﹤0.01% 1459
2020
Q4
Sell
-335
Closed -$57K 1841
2020
Q3
$57K Buy
+335
New +$61.9K ﹤0.01% 1236
2014
Q1
Sell
-1,100
Closed -$49.4K 2726
2013
Q4
$51K Sell
1,100
-4,200
-79% -$213K ﹤0.01% 1757
2013
Q3
$279K Buy
+5,300
New +$257K 0.01% 1016

Other funds holding RMD

Wolverine Asset Management's RMD Position: Q2 2021 in Review

Wolverine Asset Management sold out of ResMed (RMD) in Q2 2021, closing a stake of 500 shares — an estimated $97K sold.

Wolverine Asset Management first reported a position in RMD in Q3 2013 and held it in 4 quarters. The position peaked at $279K in Q3 2013. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

  • Wolverine Asset Management reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 500 ResMed shares in Q2 2021, an estimated $97K.
  • Wolverine Asset Management first reported a position in ResMed in Q3 2013 and held it in 4 quarters.
  • Wolverine Asset Management's ResMed position peaked at $279K in Q3 2013.
  • 661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.